Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
| Image |  |
|---|---|
| Description | scientific article published on April 9, 2013 |
| Author/s | |
| Publication date | April 9, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/bcr3411 |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |